pharmaceuticals
pharmaceuticals Articles
Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Published:
Last Updated:
Ra Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains.
Published:
Last Updated:
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
Published:
Last Updated:
Mylan just has been unable to recover from its EpiPen pricing hike issue. Thursday's additional weakness was tied to a late Wednesday report from U.S. federal health regulators.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Published:
Last Updated:
Pfizer shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into two companies.
Published:
Last Updated:
A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately to severely active Crohn's disease.
Published:
Last Updated:
24/7 Wall St. has picked out some of the major companies in the health care sector that are moving ahead of the first presidential debate and added in some color for each.
Published:
Last Updated:
In a time when government wrangling about drug prices is more than commonplace, news of a biosimilar for the mega-blockbuster Humira being approved took the backseat to many other things.
Published:
Last Updated:
The week of September 23 brought numerous analyst upgrades and downgrades in the biotech and biohealth space.
Published:
Last Updated:
Shares of Endo International saw a handy gain in Friday’s session after the company named its new president and chief executive officer.
Published:
Last Updated:
Tobira Therapeutics shares skyrocketed on Tuesday after Allergan announced that it will acquire the company.
Published:
Last Updated:
An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four top biotech companies may be a solid play now.
Published:
Last Updated: